Test method: GH

被引:56
作者
Bidlingmaier, M [1 ]
Wu, ZD [1 ]
Strasburger, CJ [1 ]
机构
[1] Univ Munich, Klinikum Innenstadt, Dept Internal Med, Neuroendocrine Unit, D-80336 Munich, Germany
关键词
growth hormone; recombinant growth hormone; immunoassay; isoforms; IGF-I; IGFBP-3; ALS;
D O I
10.1053/beem.2000.0057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The abuse of recombinant human growth hormone in sports is considered to be a widespread phenomenon, but until today all our knowledge thereof is based on rumour, anonymous surveys or accidental observations by customs officers. Although growth hormone (GH) is listed as a prohibited class E substance by the International Olympic Committee(IOC) no official test for the detection of GH abuse is implemented. Because of the high degree of identity in the amino acid sequence between recombinant and endogenous GH and because of the pulsatile nature of GH secretion, as well as inter-individual variations, it was believed to be undetectable. Recently, new proposals have been made to overcome this problem. On the basis of differential immunoassays it is possible to determine the relative content of GH isoforms in the circulation and thus to detect the application of recombinant GH. Furthermore, changes in GH dependent parameters after the administration of recombinant GH have been shown to be a possible indicator of GH abuse.
引用
收藏
页码:99 / 109
页数:11
相关论文
共 29 条
  • [1] Isotopic differences in human growth hormone preparations
    Abramson, FP
    Osborn, BL
    Teffera, Y
    [J]. ANALYTICAL CHEMISTRY, 1996, 68 (11) : 1971 - 1972
  • [2] CAPILLARY ELECTROPHORESIS FOR PROTEIN-ANALYSIS - SEPARATION OF HUMAN GROWTH-HORMONE AND HUMAN INSULIN MOLECULAR-FORMS
    ARCELLONI, C
    FERMO, I
    BANFI, G
    PONTIROLI, AE
    PARONI, R
    [J]. ANALYTICAL BIOCHEMISTRY, 1993, 212 (01) : 160 - 167
  • [3] EXERCISE-INDUCED CHANGES IN INSULIN-LIKE GROWTH-FACTORS AND THEIR LOW-MOLECULAR-WEIGHT BINDING-PROTEIN IN HEALTHY-SUBJECTS AND PATIENTS WITH GROWTH-HORMONE DEFICIENCY
    BANG, P
    BRANDT, J
    DEGERBLAD, M
    ENBERG, G
    KAIJSER, L
    THOREN, M
    HALL, K
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (03) : 285 - 292
  • [4] BAUMANN G, 1990, ACTA PAEDIATR SCAND, P72
  • [5] Growth hormone heterogeneity in human pituitary and plasma
    Baumann, G
    [J]. HORMONE RESEARCH, 1999, 51 : 2 - 6
  • [6] The ethics of blood testing as an element of doping control in sport
    Browne, A
    Lachance, V
    Pipe, A
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1999, 31 (04) : 497 - 501
  • [7] Physical fitness, endurance training, and the growth hormone insulin-like growth factor I system in adolescent females
    Eliakim, A
    Brasel, JA
    Mohan, S
    Barstow, TJ
    Berman, N
    Cooper, DM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) : 3986 - 3992
  • [8] Urinary growth hormone following exercise to assess growth hormone production in adults
    Flanagan, DEH
    Taylor, MC
    Parfitt, V
    Mardell, R
    Wood, PJ
    Leatherdale, BA
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (04) : 425 - 429
  • [9] Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3
    Harrela, M
    Koistinen, H
    Kaprio, J
    Lehtovirta, M
    Tuomilehto, J
    Eriksson, J
    Tolvanen, L
    Koskenvuo, M
    Leinonen, P
    Koistinen, R
    Seppala, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) : 2612 - 2615
  • [10] Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone
    Hashimoto, Y
    Ikeda, I
    Ikeda, M
    Takahashi, Y
    Hosaka, M
    Uchida, H
    Kono, N
    Fukui, H
    Makino, T
    Honjo, M
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 221 (1-2) : 77 - 85